Similar articles

• Pharmaceuticals issue brief: pharmaceuticals cost control: year end report--2004.

  Seay M. Seay M. Issue Brief Health Policy Track Serv. 2004 Dec 31:1-17. Issue Brief Health Policy Track Serv. 2004. PMID: 15724308 No abstract available.
• Pharmaceuticals: generic/ therapeutic drug substitution: year end report-2002.

  Floridi T, Kammer C. Floridi T, et al. Issue Brief Health Policy Track Serv. 2002 Dec 31:1-12. Issue Brief Health Policy Track Serv. 2002. PMID: 12856672 No abstract available.
• Pharmaceuticals: pharmaceutical cost control measures: year end report-2002.

  Kammer C. Kammer C. Issue Brief Health Policy Track Serv. 2002 Dec 31:1-14. Issue Brief Health Policy Track Serv. 2002. PMID: 12856689 No abstract available.
• Current approaches to the use of generic antiepileptic drugs.

  Krämer G, Biraben A, Carreno M, Guekht A, de Haan GJ, Jedrzejczak J, Josephs D, van Rijckevorsel K, Zaccara G. Krämer G, et al. Epilepsy Behav. 2007 Aug;11(1):46-52. doi: 10.1016/j.yebeh.2007.03.014. Epub 2007 May 29. Epilepsy Behav. 2007. PMID: 17537678 Review.
• Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance.

  Godman B, Wettermark B, Hoffmann M, Andersson K, Haycox A, Gustafsson LL. Godman B, et al. Expert Rev Pharmacoecon Outcomes Res. 2009 Feb;9(1):65-83. doi: 10.1586/14737167.9.1.65. Expert Rev Pharmacoecon Outcomes Res. 2009. PMID: 19371180 Review.